- Emma McCance appointed as formulation chemist to focus on cosmetic product development
- Damien Hancox, CEO, says appointment is a key step in building SpectrumX’s in-house technical team to develop its HOCl-based cosmetics line
London – SpectrumX, a UK-based healthcare and pharmaceutical company, today announces an integral addition to its technical team, with the appointment of Emma McCance as formulation chemist. Reporting to Annaliese Waite, technical manager, McCance will be responsible for developing and optimising product formulations, a key step in bringing SpectrumX’s new cosmetics line to market.
The hire emphasises the SpectrumX’s commitment to building a robust in-house technical team that has the deep knowledge of molecular compounds to develop the Company’s proprietary formulation of stablilised hypochlorous acid (HOCl) for skincare, which will form the basis of the cosmetics line.
HOCl has been gaining ground as a popular ingredient in skincare products due to its gentle antimicrobial properties. According to the Cleveland Clinic, HOCl promotes wound healing and protects the skin barrier, as well as providing benefits to a range of conditions, acne, eczema, and psoriasis.
In her role, McCance will focus on designing and developing product formulations to ensure performance, safety, and efficacy. She will source ingredients, create prototypes, and scale products for manufacture. McCance will also ensure that products meet the necessary regulatory requirements.
With more than six years’ experience as a chemist, McCance brings a breadth of expertise in product development and quality control. She joins SpectrumX from MPM Consumer Products Ltd, a manufacturer of household and personal care products, where she worked as a formulation chemist for cosmetics. She holds a BSc in chemistry from the University of Huddersfield.
Damien Hancox, CEO of SpectrumX, said: “We are thrilled to welcome Emma, who will play a pivotal role in building the in-house expertise to innovate and develop our cosmetics line, which has the largest scope of product possibilities. Emma’s experience in formulation and in-depth knowledge of molecular ingredient compatibility will be an asset as we create a line of products to cleanse, tone, and repair skin for future rollout across B2B and B2C markets.”
Emma McCance said: “I am excited to joining SpectrumX and contribute to the development of safe, effective cosmetics products based on the novel properties of HOCl. The cosmetics industry is just beginning to scratch the surface on what HOCl can bring to the cosmetics market, and I look forward to combining my expertise with SpectrumX’s scientific breakthroughs to bring this innovation to market.”